Filing Details

Accession Number:
0001127602-24-017958
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-06-05 17:04:40
Reporting Period:
2024-05-31
Accepted Time:
2024-06-05 17:04:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1830214 Ginkgo Bioworks Holdings Inc. DNA Biological Products, (No Disgnostic Substances) (2836) 872652913
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1873507 E. Mark Dmytruk C/O Ginkgo Bioworks Holdings, Inc.
27 Drydock Avenue
Boston MA 02210
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2024-05-31 65,448 $0.00 990,848 No 4 M Direct
Class A Common Stock Acquisiton 2024-05-31 18,125 $0.00 1,008,973 No 4 M Direct
Class A Common Stock Acquisiton 2024-05-31 22,917 $0.00 1,031,890 No 4 M Direct
Class A Common Stock Acquisiton 2024-05-31 1,638 $0.00 1,033,528 No 4 M Direct
Class A Common Stock Disposition 2024-06-03 48,866 $0.55 984,662 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Restricted Stock Units Disposition 2024-05-31 65,448 $0.00 65,448 $0.00
Class A Common Stock Restricted Stock Units Disposition 2024-05-31 18,125 $0.00 18,125 $0.00
Class A Common Stock Restricted Stock Units Disposition 2024-05-31 22,917 $0.00 22,917 $0.00
Class A Common Stock Class B Common Stock Disposition 2024-05-31 1,638 $0.00 1,638 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
581,538 No 4 M Direct
598,125 No 4 M Direct
1,031,250 No 4 M Direct
625,412 No 4 M Direct
Footnotes
  1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
  2. Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock.
  3. Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date.
  4. Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.
  5. The RSUs vest in 48 equal monthly installments, which began on April 1, 2023.
  6. The RSUs vest in 48 equal monthly installments, which began on April 1, 2024.
  7. Includes shares of Class B Common Stock that are subject to vesting conditions.